Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-08-17
1992-11-24
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, A61K 4902, A61K 4900
Patent
active
051659123
ABSTRACT:
A diagnostic reagent for the detection in vivo of increased release of a fibrinolytic enzyme or increased fibrinolytic activity in the human or animal body comprises an antibody reactive with a fibrinolytic enzyme, or a biologically active fragment of the antibody, labelled with a substance which permits the detection in vivo of binding of the antibody to the fibrinolytic enzyme. In one embodiment, increased clearance of the antibody is provided by subsequent administration of the fibrinolytic enzyme with which the antibody is reactive. The fibrinolytic enzyme is preferably t-PA.
REFERENCES:
Krohn, K. A. et al., Sem. Nucl. Med. 7(3):219-228 (Jul. 1977).
Peters, A. M. et al., Brit. Med. J. 293:1525-1527 (13 Dec. 1986).
Paulsma-De Waal, J. H. et al., NucCompact 18:284-286 (1987).
Rosebrough, S. F. et al., Radiology 156(2):515-517 (1985).
Rosebrough, S. F. et al., Radiology 162(2):575-577 (1987).
Knight, L. C. et al., J. Nucl. Med. 29:494-502 (1988).
Jung, M. et al., Eur. J. Nucl. Med. 14:246 (1988)(Abstr. 143).
Ahonen, A. et al., Eur. J. Nucl. Med. 14:309 (1988)(Abstr. 522).
DeGeeter, F. et al., Eur. J. Nucl. Med. 14:246 (1988)(Abstr. 144).
Oster, Z. et al., Am. J. Radiology 152:253-260 (1989).
Stuttle, A. W. J. et al., Eur. J. Nucl. Med. 14:256 (1988)(Abstr. 201).
Som, P. et al., J. Nucl. Med. 27(8):1315-1320 (Aug. 1986).
Hnatowich, D. J. et al., Eur. J. Nucl. Med. 13:467-473 (1987).
Karonen, S.-L. et al., J. Nucl. Med. 29:1194-1199 (1988).
Karonen, S.-L. et al., Eur. J. Nucl. Med 14:252 (1988)(Abstr. 180).
Hnatowich, D. J. et al., Science 220:613-615 (1983).
Rhodes, B. A. et al., in Tumor Imaging (S. W. Burchiel et al., eds.), New York, Mason Pub., pp. 111-123 (1982).
Cerdan, S. et al., Magnetic Resonance in Medicine 12:151-163 (1989).
Saccavini, J. C. et al., Invest. Radiol. Supp. 1:S292-S293 (1988).
Hnatowich, D. J., Immun. Methods 65:147-157 (1983).
De Geeter, F. et al., Eur. J. Nucl. Med. 14:270 (1988), (Abstract No. 285).
Selmer Johan
Tromholt Niels
Maples John S.
Novo Nordisk A S
LandOfFree
Method for the detection of fibrinolytic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the detection of fibrinolytic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the detection of fibrinolytic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-920286